首页|期刊导航|Hepatobiliary & Pancreatic Diseases International|Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence:A multicenter prospective cohort study

Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence:A multicenter prospective cohort study

Jin-Hong Chen Lu Lu Xiao-Yun Zhang Bang-De Xiang Xiao Xu Xiang-Cheng Li Zhi-Yong Huang Tian-Fu Wen Liu-Ping Luo Jing Huang Jian-Hong Zhong Zhi-Kun Liu Chang-Xian Li Xin Long Wen-Wei Zhu Xin Yang Chao-Qun Wang Hu-Liang Jia Ju-Bo Zhang Yong-Yi Zeng Cai-De Lu Lun-Xiu Qin

Hepatobiliary & Pancreatic Diseases International2025，Vol.24Issue(3)：P.277-285,9.

Hepatobiliary & Pancreatic Diseases International2025，Vol.24Issue(3)：P.277-285,9.DOI:10.1016/j.hbpd.2025.03.001

Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence:A multicenter prospective cohort study

Jin-Hong Chen ¹Lu Lu ¹Xiao-Yun Zhang ²Bang-De Xiang ³Xiao Xu ⁴Xiang-Cheng Li ⁵Zhi-Yong Huang ⁶Tian-Fu Wen ²Liu-Ping Luo ⁷Jing Huang ⁸Jian-Hong Zhong ³Zhi-Kun Liu ⁹Chang-Xian Li ⁵Xin Long ⁶Wen-Wei Zhu ¹Xin Yang ¹Chao-Qun Wang ¹Hu-Liang Jia ¹Ju-Bo Zhang ¹⁰Yong-Yi Zeng ⁷Cai-De Lu ⁸Lun-Xiu Qin¹

作者信息

1. Hepatobiliary Surgery Center,Department of General Surgery,Huashan Hospital&Cancer Metastasis Institute,Fudan University,Shanghai 200040,China
2. Department of Liver Surgery,West China Hospital of Sichuan University,Chengdu 610041,China
3. Hepatobiliary Surgery Department,Guangxi Medical University Cancer Hospital,Nanning 537406,China
4. Institute of Translational Medicine,Zhejiang University School of Medicine,Hangzhou 310000,China Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province,Hangzhou 310006,China
5. Hepatobiliary Center,the First Affiliated Hospital,Nanjing Medical University,Key Laboratory of Liver Transplantation,Chinese Academy of Medical Sciences,Nanjing 210029,China
6. Hepatic Surgery Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
7. Department of Hepatobiliary Surgery,Mengchao Hepatobiliary Hospital,Fujian Medical University,Fuzhou 350025,China
8. Department of Hepato-Pancreato-Biliary Surgery,Ningbo Medical Center Lihuili Hospital,Ningbo University,Ningbo 315048,China
9. Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province,Hangzhou 310006,China Department of Hepatobiliary and Pancreatic Surgery,Hangzhou First People’s Hospital,Hangzhou 310006,China
10. Department of Infectious Diseases,Huashan Hospital,Fudan University,Shanghai 200040,China
折叠

摘要

关键词

Hepatocellular carcinoma/Lenvatinib/Transarterial chemoembolization/Postoperative recurrence/Disease-free survival

分类

医药卫生

引用本文复制引用

Jin-Hong Chen,Lu Lu,Xiao-Yun Zhang,Bang-De Xiang,Xiao Xu,Xiang-Cheng Li,Zhi-Yong Huang,Tian-Fu Wen,Liu-Ping Luo,Jing Huang,Jian-Hong Zhong,Zhi-Kun Liu,Chang-Xian Li,Xin Long,Wen-Wei Zhu,Xin Yang,Chao-Qun Wang,Hu-Liang Jia,Ju-Bo Zhang,Yong-Yi Zeng,Cai-De Lu,Lun-Xiu Qin..Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence:A multicenter prospective cohort study[J].Hepatobiliary & Pancreatic Diseases International,2025,24(3):P.277-285,9.

基金项目

supported by grants from the National Natural Science Foundation of China(91959203,82272836 and 82373017)。（91959203,82272836 and 82373017）

Hepatobiliary & Pancreatic Diseases International

ISSN：1499-3872

访问量3

下载量0

段落导航